A small group of HIV-1-infected individuals, called long-term nonprogressors (LTNPs), and in particular a subgroup of LTNPs, elite controllers (LTNP-ECs), display permanent control of viral replication and lack of clinical progression. This control is the result of a complex interaction of host, immune, and viral factors. We identified, by phylogenetic analysis, a cluster of LTNP-ECs infected with very similar low-replication HIV-1 viruses, suggesting the contribution of common viral features to the clinical LTNP-EC phenotype. HIV-1 envelope (Env) glycoprotein mediates signaling and promotes HIV-1 fusion, entry, and infection, being a key factor of viral fitness , cytopathicity, and infection progression Therefore, we isolated full-length ...
The characteristics of intra-host human immunodeficiency virus type 1 (HIV-1) env evolution were eva...
Increasing evidence suggests that durable drug-free control of HIV-1 replication is enabled by effec...
<div><p>In the absence of antiretroviral therapy, infection with human immunodeficiency virus type 1...
A small group of HIV-1-infected individuals, called long-term nonprogressors (LTNPs), and in particu...
<div><p>Long term non-progressor patients (LTNPs) are characterized by the natural control of HIV-1 ...
International audienceObjective: HIV-1 transmission leads to a genetic bottleneck, with one or a few...
To study the causes for the lack of clinical progression in a superinfected HIV-1 LTNP elite control...
Long term non-progressor patients (LTNPs) are characterized by the natural control of HIV-1 infectio...
Long term non-progressor patients (LTNPs) are characterized by the natural control of HIV-1 infectio...
To study the causes for the lack of clinical progression in a superinfected HIV-1 LTNP elite control...
BACKGROUND: The Sydney blood bank cohort (SBBC) of long-term survivors consists of multiple individu...
Defining the virus-host interactions responsible for HIV-1 transmission, including the phenotypic re...
For HIV to enter cells, the viral surface protein Envelope (Env) must sequentially bind the host pro...
Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control ...
Defining the virus�host interactions responsible for HIV-1 transmission, including the phenotypic ...
The characteristics of intra-host human immunodeficiency virus type 1 (HIV-1) env evolution were eva...
Increasing evidence suggests that durable drug-free control of HIV-1 replication is enabled by effec...
<div><p>In the absence of antiretroviral therapy, infection with human immunodeficiency virus type 1...
A small group of HIV-1-infected individuals, called long-term nonprogressors (LTNPs), and in particu...
<div><p>Long term non-progressor patients (LTNPs) are characterized by the natural control of HIV-1 ...
International audienceObjective: HIV-1 transmission leads to a genetic bottleneck, with one or a few...
To study the causes for the lack of clinical progression in a superinfected HIV-1 LTNP elite control...
Long term non-progressor patients (LTNPs) are characterized by the natural control of HIV-1 infectio...
Long term non-progressor patients (LTNPs) are characterized by the natural control of HIV-1 infectio...
To study the causes for the lack of clinical progression in a superinfected HIV-1 LTNP elite control...
BACKGROUND: The Sydney blood bank cohort (SBBC) of long-term survivors consists of multiple individu...
Defining the virus-host interactions responsible for HIV-1 transmission, including the phenotypic re...
For HIV to enter cells, the viral surface protein Envelope (Env) must sequentially bind the host pro...
Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control ...
Defining the virus�host interactions responsible for HIV-1 transmission, including the phenotypic ...
The characteristics of intra-host human immunodeficiency virus type 1 (HIV-1) env evolution were eva...
Increasing evidence suggests that durable drug-free control of HIV-1 replication is enabled by effec...
<div><p>In the absence of antiretroviral therapy, infection with human immunodeficiency virus type 1...